| Literature DB >> 33995580 |
Tamás Resál1, Renáta Bor1, Kata Szántó1, Anna Fábián1, Mariann Rutka1, Marco Sacco2, Davide Guiseppe Ribaldone3, Pauliina Molander4, Stephane Nancey5, Uri Kopylov6, Stephan Vavricka7, David Drobne8, Milan Lukas9, Klaudia Farkas1, Zoltán Szepes1, Tamás Molnár10.
Abstract
INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic poses a challenge to healthcare. Staff and patients are at increased risk during an examination or intervention, so certain restrictions ought to be introduced. Hence, we aimed to measure the effect of the pandemic on endoscopy units in real-life settings.Entities:
Keywords: SARS-CoV-2; coronavirus; endoscopy; pandemia; personal protective equipment
Year: 2021 PMID: 33995580 PMCID: PMC8072846 DOI: 10.1177/17562848211006678
Source DB: PubMed Journal: Therap Adv Gastroenterol ISSN: 1756-283X Impact factor: 4.409
The distribution of responses among countries.
| Country | Questionnaires filled (%) | COVID-19 prevalence |
|---|---|---|
| Belgium | 2 (0.6) | High |
| Canada | 2 (0.6) | Medium |
| Croatia | 12 (3.8) | Medium |
| Czech Republic | 20 (6.4) | Medium |
| Finland | 23 (7.4) | Low |
| France | 22 (7.1) | High |
| Germany | 2 (0.6) | Medium |
| Hungary | 120 (38.5) | Low |
| Israel | 7 (2.2) | High |
| Italy | 32 (10.3) | Medium |
| Romania | 13 (4.2) | Medium |
| Slovakia | 7 (2.2) | Low |
| Slovenia | 27 (8.7) | Low |
| Switzerland | 22 (7.1) | High |
| United Arabian Emirates | 1 (0.3) | High |
| Overall | 312 |
COVID-19 prevalence (cases per one million people, since the outbreak until 1 September) is classified to low (0–2000 cases/million), medium (2000–5000 cases/million), and high-risk (>5000 cases/million) countries.
COVID-19, coronavirus disease 2019.
Figure 1.Usage of available necessary protective equipment [FFP2 (N95)/FFP3 (N99) (Filtering Face Piece), protective eyewear, double gloves] in endoscopy labs; 1 point when only one was used, 2 when two of them were used, and 3 when all of them were used (mean values based on countries).FFP, Filtering Face Piece.
Significance (p-values) in terms of the presence of the protective equipment during an examination of a high-risk, or COVID-19 positive patient.
| Czech Republic | Finland | France | Hungary | Italy | Slovenia | |
|---|---|---|---|---|---|---|
| Finland | 0.999 | – | 0.494 | <0.001 | 0.7503 | 0.999 |
| France | 0.999 | 0.494 | – | 0.494 | 0.999 | 0.999 |
| Hungary | 0.0065 | <0.001 | 0.494 | – | 0.03547 | 0.00199 |
| Italy | 0.999 | 0.7503 | 0.999 | 0.03547 | – | 0.999 |
| Slovenia | 0.999 | 0.999 | 0.999 | 0.00199 | 0.999 | – |
| Switzerland | 0.999 | 0.999 | 0.999 | 0.02733 | 0.999 | 0.999 |
The results were significant, when data were compared with Hungarian results.
COVID-19, coronavirus disease 2019.
Figure 2.Indications for endoscopic procedures (divided into low and high-risk group) in which endoscopy cannot be postponed after the pandemic based on the opinion of our cohort.
Figure 3.Availablity of appropriate amount of personal protective equipment.
Figure 4.Personal protective equipment (PPE) used in high-risk or positive cases.
Results of survey regarding workflow and infection prevention and control strategies of endoscopy unit during the COVID-19 pandemic.
| Indications for endoscopic procedures during COVID-19 pandemic | |
| Acute life-threatening gastrointestinal disease | • Severe cholangitis, acute biliary pancreatitis with cholangitis, biliary leakage |
| Clinical conditions causing potentially permanent health damage if endoscopy is postponed | • Suspicion of gastrointestinal malignancy (based on the results of laboratory tests, clinical status and/or cross-sectional imaging) |
| Health professional personal protective equipment | |
| Low-risk patient | • Surgical mask |
| High-risk or SARS-CoV2 positive patient | • FFP-2/3 mask |
COVID-19, coronavirus disease 2019; FFP, Filtering Face Piece; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.